This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/513395-eu-astrazeneca-covid-vaccine-delay/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| EU Commission, member states ‘deeply dissatisfied’ with AstraZeneca after revelation of delayed vaccine delivery | EU Commission, member states ‘deeply dissatisfied’ with AstraZeneca after revelation of delayed vaccine delivery |
| (about 2 months later) | |
| AstraZeneca has warned the EU’s executive that there will be delays to its delivery of Covid-19 vaccines in the first three months of the year, prompting the bloc’s health commissioner to express “deep dissatisfaction.” | AstraZeneca has warned the EU’s executive that there will be delays to its delivery of Covid-19 vaccines in the first three months of the year, prompting the bloc’s health commissioner to express “deep dissatisfaction.” |
| In a series of tweets late Friday, EU Commissioner for Health Stella Kyriakides said the delays had been revealed by representatives for the British-Swedish pharma firm earlier that day “compared to the forecast for the first quarter of this year.” | In a series of tweets late Friday, EU Commissioner for Health Stella Kyriakides said the delays had been revealed by representatives for the British-Swedish pharma firm earlier that day “compared to the forecast for the first quarter of this year.” |
| “The EU Commission and Member States expressed deep dissatisfaction with this,” she added. | “The EU Commission and Member States expressed deep dissatisfaction with this,” she added. |
| EU regulators have not yet approved the vaccine, jointly developed by AstraZeneca and the UK’s Oxford University, but the bloc has pre-ordered up to 400 million doses, of which about 80 million were due to be delivered by March. | EU regulators have not yet approved the vaccine, jointly developed by AstraZeneca and the UK’s Oxford University, but the bloc has pre-ordered up to 400 million doses, of which about 80 million were due to be delivered by March. |
| A senior EU official told Reuters that the reduced figure means a drop of 60 percent in the delivery for that period, to 31 million doses. | A senior EU official told Reuters that the reduced figure means a drop of 60 percent in the delivery for that period, to 31 million doses. |
| The European Medicines Agency’s decision on approving the conditional marketing authorization of the vaccine could be made before the end of this month. Clinical trials have reported it has a 94.5 percent efficacy against Covid-19. | The European Medicines Agency’s decision on approving the conditional marketing authorization of the vaccine could be made before the end of this month. Clinical trials have reported it has a 94.5 percent efficacy against Covid-19. |
| The AstraZeneca inoculation is relatively easier to handle than some others given it can be stored at 2-8 degrees Celsius, compared to Sputnik V’s -18C, Moderna’s -20C, and Pfizer’s -70C. | The AstraZeneca inoculation is relatively easier to handle than some others given it can be stored at 2-8 degrees Celsius, compared to Sputnik V’s -18C, Moderna’s -20C, and Pfizer’s -70C. |
| News of the AstraZenca hiccup comes after the EU said it was seeking "clarification" from Pfizer over further reductions to its deliveries, having previously announced a fall in deliveries as it works to upgrade manufacturing capacity in Belgium. | News of the AstraZenca hiccup comes after the EU said it was seeking "clarification" from Pfizer over further reductions to its deliveries, having previously announced a fall in deliveries as it works to upgrade manufacturing capacity in Belgium. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |